Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Two obesity drugs approved last year by the FDA were rejected in Europe, and one doctor says the side effects of the drugs make them too dangerous to be prescribed.
Did the Food and Drug Administration push through dangerous drugs due to influence from big pharma? That?s the question that senior doctor Sidney M. Wolfe, MD, founder of the health research group Public Citizen, is asking in a new paper published in the journal BMJ after the FDA approved two weight-loss drugs that the European Medicine Agency (EMA), the European equivalent of the FDA, rejected due to concerns over side effects.
The drugs, Belviq and Qsymia, were both approved in the United States last summer, despite the concerns over side effects, including heart disease and depression, which led to both drugs being repeatedly denied by the EMA.
http://www.everydayhealth.com/healt...n-approved-expert-says.aspx?xid=RSS_EHlinkrss
Did the Food and Drug Administration push through dangerous drugs due to influence from big pharma? That?s the question that senior doctor Sidney M. Wolfe, MD, founder of the health research group Public Citizen, is asking in a new paper published in the journal BMJ after the FDA approved two weight-loss drugs that the European Medicine Agency (EMA), the European equivalent of the FDA, rejected due to concerns over side effects.
The drugs, Belviq and Qsymia, were both approved in the United States last summer, despite the concerns over side effects, including heart disease and depression, which led to both drugs being repeatedly denied by the EMA.
http://www.everydayhealth.com/healt...n-approved-expert-says.aspx?xid=RSS_EHlinkrss